Detalles de la búsqueda
1.
A phase II clinical trial evaluating the safety and efficacy of durvalumab as first line therapy in advanced and metastatic non-small cell lung cancer patients with Eastern Cooperative Oncology Group performance status of 2.
EClinicalMedicine
; 66: 102317, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38192592
Resultados
1 -
1
de 1
1
Próxima >
>>